These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26439473)

  • 1. Comparative effects of group metacognitive therapy versus behavioural activation in moderately depressed students.
    Zemestani M; Davoodi I; Honarmand MM; Zargar Y; Ottaviani C
    J Ment Health; 2016 Dec; 25(6):479-485. PubMed ID: 26439473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group metacognitive therapy for adolescents with anxiety and depressive disorders: A pilot study.
    Thorslund J; McEvoy PM; Anderson RA
    J Clin Psychol; 2020 Apr; 76(4):625-645. PubMed ID: 31916590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group Metacognitive Therapy vs. Mindfulness Meditation Therapy in a Transdiagnostic Patient Sample: A Randomised Feasibility Trial.
    Capobianco L; Reeves D; Morrison AP; Wells A
    Psychiatry Res; 2018 Jan; 259():554-561. PubMed ID: 29179137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alleviating Emotional Distress in Adolescent and Young Adult Cancer Survivors: An Open Trial of Metacognitive Therapy.
    Fisher PL; McNicol K; Young B; Smith E; Salmon P
    J Adolesc Young Adult Oncol; 2015 Jun; 4(2):64-9. PubMed ID: 26812553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram and metacognitive therapy for depressive symptoms and cognitive emotion regulation in patients with major depressive disorder: A randomized controlled trial.
    Kheirabadi GR; Yousefian Z; Zargar F; Bahrami M; Maracy MR
    J Educ Health Promot; 2020; 9():6. PubMed ID: 32154301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdiagnostic cognitive behavioural treatment and the impact of co-morbidity: An open trial in a cohort of primary care patients.
    Kristjánsdóttir H; Salkovskis PM; Sigurdsson BH; Sigurdsson E; Agnarsdóttir A; Sigurdsson JF
    Nord J Psychiatry; 2016; 70(3):215-23. PubMed ID: 26403998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in cognitive biases after group psychoeducation and metacognitive training in recent-onset psychosis: A randomized crossover clinical trial.
    Ahuir M; Cabezas Á; Miñano MJ; Algora MJ; Estrada F; Solé M; Gutiérrez-Zotes A; Tost M; Barbero JD; Montalvo I; Sánchez-Gistau V; Monreal JA; Vilella E; Palao D; Labad J
    Psychiatry Res; 2018 Dec; 270():720-723. PubMed ID: 30551315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Decentering and Reappraisal Temporally Precede Symptom Reduction During Emotion Regulation Therapy for Generalized Anxiety Disorder With and Without Co-Occurring Depression.
    O'Toole MS; Renna ME; Mennin DS; Fresco DM
    Behav Ther; 2019 Nov; 50(6):1042-1052. PubMed ID: 31735240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in neuropsychological function after treatment with metacognitive therapy or cognitive behavior therapy for depression.
    Groves SJ; Porter RJ; Jordan J; Knight R; Carter JD; McIntosh VV; Fernando K; Frampton CM; Mulder RT; Lacey C; Joyce PR
    Depress Anxiety; 2015 Jun; 32(6):437-44. PubMed ID: 25677736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open trial of group metacognitive therapy for depression in Norway.
    Dammen T; Papageorgiou C; Wells A
    Nord J Psychiatry; 2015 Feb; 69(2):126-31. PubMed ID: 25124119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metacognitive therapy versus cognitive behavioural therapy for depression: a randomized pilot study.
    Jordan J; Carter JD; McIntosh VV; Fernando K; Frampton CM; Porter RJ; Mulder RT; Lacey C; Joyce PR
    Aust N Z J Psychiatry; 2014 Oct; 48(10):932-43. PubMed ID: 24810871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emotion regulation as the mediator of reductions in anxiety and depression in the Unified Protocol (UP) for transdiagnostic treatment of emotional disorders: double-blind randomized clinical trial.
    Khakpoor S; Saed O; Armani Kian A
    Trends Psychiatry Psychother; 2019; 41(3):227-236. PubMed ID: 31644691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial.
    Kunik ME; Veazey C; Cully JA; Souchek J; Graham DP; Hopko D; Carter R; Sharafkhaneh A; Goepfert EJ; Wray N; Stanley MA
    Psychol Med; 2008 Mar; 38(3):385-96. PubMed ID: 17922939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metacognitive therapy versus cognitive-behavioral therapy in adults with generalized anxiety disorder: A 9-year follow-up study.
    Solem S; Wells A; Kennair LEO; Hagen R; Nordahl H; Hjemdal O
    Brain Behav; 2021 Oct; 11(10):e2358. PubMed ID: 34520637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of metacognitive therapy for anxiety and depression: a meta-analytic review.
    Normann N; van Emmerik AA; Morina N
    Depress Anxiety; 2014 May; 31(5):402-11. PubMed ID: 24756930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief Behavioural Activation (Brief BA) for Adolescent Depression: A Pilot Study.
    Pass L; Lejuez CW; Reynolds S
    Behav Cogn Psychother; 2018 Mar; 46(2):182-194. PubMed ID: 28756787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metacognitive therapy in treatment-resistant psychosis: a multiple-baseline study.
    Hutton P; Morrison AP; Wardle M; Wells A
    Behav Cogn Psychother; 2014 Mar; 42(2):166-85. PubMed ID: 23286558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving functional outcome in bipolar disorder: A pilot study on metacognitive training.
    Haffner P; Quinlivan E; Fiebig J; Sondergeld LM; Strasser ES; Adli M; Moritz S; Stamm TJ
    Clin Psychol Psychother; 2018 Jan; 25(1):50-58. PubMed ID: 28857347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of short-term psychodynamic psychotherapy and solution-focused therapy in the treatment of depressive and anxiety disorders during a one-year follow-up.
    Maljanen T; Paltta P; Harkanen T; Virtala E; Lindfors O; Laaksonen MA; Knekt P;
    J Ment Health Policy Econ; 2012 Mar; 15(1):13-23. PubMed ID: 22611089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care.
    King M; Sibbald B; Ward E; Bower P; Lloyd M; Gabbay M; Byford S
    Health Technol Assess; 2000; 4(19):1-83. PubMed ID: 11086269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.